• Abrass CK, Border WA, Hepner G. Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin. Exp. Immunol. 40: 292-298 (1980). *

• Adler M, Chung KW, Schaffner F. Pericanalicular hepatocytic and bile ductular microfilaments in cholestasis in man. Am. J. Pathol. 98: 603-616 (1980).

• Adour KK, Byl FM, Hilsinger RL Jr, Wilcox RD. Meniere's disease as a form of cranial polyganglionitis. Laryngoscope 90: 392-398 (1980).

• Ahlqvist J. Can endocrine factors influence pathogenetic mechanisms in chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC)? A hypothesis. Hepatogastroenterology 27: 64-67 (1980).

• Amoroso P, Vergani D, Wojcicka BM, McFarlane IG, Eddleston AL, Tee DE, Williams R. Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. Clin. Exp. Immunol. 42: 95-98 (1980). *

• Arborgh B, Eklund A, Norman A, Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand. J. Gastroenterol. 15: 73-80 (1980).

• Auer IO, Ziemer E, Sommer H. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Clin. Exp. Immunol. 42: 41-49 (1980). *

• Azad Khan AK, Howes DT, Piris J, Truelove SC. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 21: 232-240 (1980). *

• Azad Khan AK, Truelove SC. Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut 21: 706-710 (1980). *

• Baines M. Clinical usefulness of the simultaneous localisation of the isoenzymes of alkaline phosphate and gamma-glutamyl transferase. Ann. Clin. Biochem. 17: 20-25 (1980).

• Balzer K, Hotz J, Goebell H. Eosinophilia as a diagnostic clue to primary sclerosing cholangitis. Z. Gastroenterol. 18: 89-93 (1980).

• Barbieri RL, Osathanondh R, Canick JA, Stillman RJ, Ryan KJ. Danazol inhibits human adrenal 21-and 11 beta-hydroxylation in vitro. Steroids 35: 251-263 (1980).

• Barbirotto RM, Fagundes-Neto U, Wehba J, Patricio FR, Michalany NS. Hereditary hemorrhagic telangiectasia associated to chronic active hepatitis. Arq. Gastroenterol. 17: 109-113 (1980).

• Bateson MC, Hill A, Bouchier IA. Analysis of response to ursodeoxycholic acid for gallstone dissolution. Digestion 20: 358-364 (1980).

• Bateson MC, Ross PE, Murison J, Saunders JH, Bouchier IA. Ursodeoxycholic acid therapy and biliary lipids - a dose-response study. Gut 21: 305-310 (1980). *

• Bayer PM, Hotschek H, Knoth E. Intestinal alkaline phosphatase and the ABO blood group system - a new aspect. Clin. Chim. Acta 108: 81-87 (1980). *

• Beckett GJ, Dewhurst N, Finlayson ND, Percy-Robb IW. Weight loss in primary biliary cirrhosis. Gut 21: 734-737 (1980). *

• Beeken WL. Transmissible agents in inflammatory bowel disease: 1980. Med. Clin. North Am. 64: 1021-1035 (1980).

• Berg PA, Wiedmann KH, Sayers T, Kloppel G, Lindner H. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 2: 1329-1332 (1980).

• Boey JH, Way LW. Acute cholangitis. Ann. Surg. 191: 264-270 (1980). *

• Bosseckert H. Relation of the biliary tract to other upper abdominal organs. Z. Gesamte. Inn. Med. 35: 672-676 (1980).

• Brandtzaeg P, Baklien K. Immunohistochemical studies of the immunoglobulin-producing cell systems of the human intestinal mucosa. Acta Histochem. Suppl. 21: 105-119 (1980).

• Bremmelgaard A, Alme B. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scand. J. Gastroenterol. 15: 593-600 (1980).

• Bremmelgaard A, Sjovall J. Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis. J. Lipid Res. 21: 1072-1081 (1980). *

• Budai K, Javitt NB. Lithocholic acid: notes on purification. J. Lipid Res. 21: 1136-1137 (1980). *

• Carulli N, Ponz de Leon M, Zironi F, Iori R, Loria P. Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. Gastroenterology 79: 637-641 (1980).

• Carulli N, Ponz De Leon M, Zironi F, Pinetti A, Smerieri A, Iori R, Loria P. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid. J. Lipid Res. 21: 35-43 (1980). *

• Caspary WF, Meyne K. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine. Digestion 20: 168-174 (1980).

• Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21: 870-877 (1980). *

• Charron L, Peyronnard JM, Marchand L. Sensory neuropathy associated with primary biliary cirrhosis. Histologic and morphometric studies. Arch. Neurol. 37: 84-87 (1980).

• Chen LJ. A simple method for the assay of bile salt sulfotransferase using glycolithocholate coupled to sepharose. Anal. Biochem. 105: 170-173 (1980). *

• Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 78: 236-246 (1980).

• Cobden I, Rothwell J, Axon AT. Intestinal permeability and screening tests for coeliac disease. Gut 21: 512-518 (1980). *

• Compston JE, Crowe JP, Wells IP, Horton LW, Hirst D, Merrett AL, Woodhead JS, Williams R. Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease. Dig. Dis. Sci. 25: 28-32 (1980).

• Cornelius CE, Bruss ML. Hepatic bile pigment excretion and erythrocyte turnover in various species. Vet. Clin. Pathol. 9: 15-20 (1980).

• Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 78: 1005-1010 (1980).

• Crowe JP, Christensen E, Butler J, Wheeler P, Doniach D, Keenan J, Williams R. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78: 1437-1441 (1980).

• Crowe JP, Molloy MG, Wells I, Thompson BR, Holborow EJ, Hamilton E, Williams R. Increased C1q binding and arthritis in primary biliary cirrhosis. Gut 21: 418-422 (1980). *

• Culvenor CC, Clarke M, Edgar JA, Frahn JL, Jago MV, Peterson JE, Smith LW. Structure and toxicity of the alkaloids of Russian comfrey (Symphytum x uplandicum Nyman), a medicinal herb and item of human diet. Experientia 36: 377-379 (1980).

• Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. Gastroenterology 78: 518-523 (1980).

• Czaja AJ, Wolf AM, Baggenstoss AH. Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings. Mayo Clin. Proc. 55: 360-364 (1980).

• Czuba B, Vessey DA. Kinetic characterization of cholyl-CoA glycine-taurine N-acyltransferase from bovine liver. J. Biol. Chem. 255: 5296-5299 (1980). *

• Degos F, Degott C, Erlinger S. Ineffectiveness of corticosteroids in cholestatic forms of chronic active hepatitis. Gastroenterol. Clin. Biol. 4: 246-250 (1980).

• Delpre G, Kadish U, Gazit E, Joshua H, Zamir R. HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology 78: 1452-1457 (1980).

• Dew MJ, van Berge Henegouwen GP, Huybregts AW, Allan RN. Hepatotoxic effect of bile acids in inflammatory bowel disease. Gastroenterology 78: 1393-1401 (1980).

• Dixit SP. Liver and the contraceptive pill. Can. J. Surg. 23: 222-227, 255 (1980).

• Douglas JG, Beckett GJ, Percy-Robb IW, Finlayson ND. Bile salt transport in the Dubin-Johnson syndrome. Gut 21: 890-893 (1980). *

• Durie PR, Bell L, Linton W, Corey ML, Forstner GG. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 21: 778-786 (1980). *

• Eade OE, Andre-Ukena SS, Moulton C, MacPherson B, Beeken WL. Lymphocyte subpopulations of intestinal mucosa in inflammatory bowel disease. Gut 21: 675-682 (1980). *

• Eade OE, Moulton C, MacPherson BR, Andre-Ukena SS, Albertini RJ, Beeken WL. Discordant HLA haplotype segregation in familial Crohn's disease. Gastroenterology 79: 271-275 (1980).

• Eaton MD. Autoimmunity induced by syngeneic splenocyte membranes carrying irreversibly adsorbed paramyxovirus. Infect. Immun. 27: 855-861 (1980). *

• Eckhauser FE, Appelman HD, O'Leary TJ, Polley TZ, Bloch DM, Turcotte JG. Hepatic pathology as a determinant of prognosis after portal decompression. Am. J. Surg. 139: 105-112 (1980).

• Engelking LR, Dasher CA, Hirschowitz BI. Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease. Am. J. Clin. Pathol. 73: 196-201 (1980).

• Enlow RW, Bias WB, Arnett FC. The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linked axial arthropathy. Arthritis Rheum. 23: 1359-1365 (1980).

• Epstein O, Boss AM, Lyon TD, Sherlock S. Hair copper in primary biliary cirrhosis. Am. J. Clin. Nutr. 33: 965-967 (1980). *

• Epstein O, Sherlock S. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis. Gastroenterology 78: 1442-1445 (1980).

• Epstein O, Thomas HC, Sherlock S. Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1: 1166-1168 (1980).

• Evans J, Newman SP, Sherlock S. Observations on copper associated protein in childhood liver disease. Gut 21: 970-976 (1980). *

• Everett GD, Mitros FA. Eosinophilic gastroenteritis with hepatic eosinophilic granulomas. Report of a case with 30-year follow-up. Am. J. Gastroenterol. 74: 519-521 (1980).

• Farid NR, Moens H, Larsen B, Payne R, Saltman K, Fifield F, Ingram DW. HLA haplotypes in familial Graves' disease. Tissue Antigens 15: 492-500 (1980).

• Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P. Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids. Am. J. Physiol. 239: G161-G166 (1980).

• Fukumoto Y, Okita K, Kodama T, Noda K, Harada T, Mizuta M, Takemoto T. Studies of alpha-napthylisothiocyanate-induced hepatic disturbance. Hepatogastroenterology 27: 457-464 (1980).

• Gal'perin EI, Kuzovlev NF. Surgical treatment of primary sclerosing cholangitis using controlled drainage. Khirurgiia (Mosk.) 2: 85-87 (1980).

• Galambos JT, Brooks WS Jr. Atypical biliary cirrhosis - or sclerosing cholangitis. J. Clin. Gastroenterol. 2: 43-52 (1980).

• Galeazzi R, Lorenzini I, Orlandi F. Rifampicin-induced elevation of serum bile acids in man. Dig. Dis. Sci. 25: 108-112 (1980).

• Geczy AF, Seager K, Bashir HV, de Vere-Tyndall A, Edmonds J. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II. Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis. J. Clin. Lab. Immunol. 3: 23-28 (1980).

• Gilmore IT, Thompson RP. Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease. Gut 21: 123-127 (1980). *

• Godeau P, Bletry O, Zafrani ES, Brion N, Chauveinc L, Galian A. Chronic hepatopathy and progressive systemic sclerosis. Frequency of association with Gougerot-Sjogren's disease. A report on six new cases. Sem. Hop. 56: 1895-1900 (1980).

• Goldfischer S, Popper H, Sternlieb I. The significance of variations in the distribution of copper in liver disease. Am. J. Pathol. 99: 715-730 (1980).

• Goldstein F, Menduke H, Thornton JJ 3rd, Abramson J. Anti-inflammatory drug treatment of Crohn's disease: a prospective evaluation of 100 consecutively treated patients. J. Clin. Gastroenterol. 2: 77-85 (1980).

• Grigorescu M, Tapalaga D, Dumitrascu D, Suciu A. Diagnostic value of serum bile acid determination in chronic hepatitis and liver cirrhosis. Med. Interne. 18: 401-406 (1980).

• Grimm L, Bircher J, Preisig R. The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein. Z. Gastroenterol. 18: 45-56 (1980).

• Hamilton SR, Keren DF, Boitnott JK, Robertson SM, Yardley JH. Enhancement by cholera toxin of IgA secretion from intestinal crypt epithelium. Gut 21: 365-369 (1980). *

• Hisadome T, Nakama T, Itoh H, Furusawa T. Physical-chemical properties of chenodeoxycholic acid and ursodeoxycholic acid. Gastroenterol. Jpn. 15: 257-263 (1980).

• Hiwatashi N, Kikuchi T, Masamune O, Ouchi E, Watanabe H, Goto Y. HLA antigens in inflammatory bowel disease. Tohoku J. Exp. Med. 131: 381-385 (1980).

• Holt PJ, Davies MG, Saunders KC, Nuki G. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 59: 114-133 (1980).

• Holzbach RT, Marsh ME, Freedman MR, Fazio VW, Lavery I, Jagelman DA. Portal vein bile acids in patients with severe inflammatory bowel disease. Gut 21: 428-435 (1980). *

• Horst DA, Grace ND, LeCompte PM. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy. Gastroenterology 79: 550-554 (1980).

• Igimi H, Carey MC. pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J. Lipid Res. 21: 72-90 (1980). *

• Iwamura K. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution. Hepatogastroenterology 27: 26-34 (1980).

• James SP, Elson CO, Waggoner JG, Jones EA, Strober W. Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. J. Clin. Invest. 66: 1305-1310 (1980). *

• Jaup BH, Zettergren LS. Familial occurrence of primary biliary cirrhosis associated with hypergammaglobulinemia in descendants: a family study. Gastroenterology 78: 549-555 (1980).

• Katono S. A comparative study of passive hemagglutination and immunofluorescence methods for the detection of mitochondrial antibodies in sera from patients with liver diseases. Gastroenterol. Jpn. 15: 233-240 (1980).

• Kaul MN, Misra RC, Agarwal SK, Saha K. Decreased gut-associated IgA levels in patients with typhoid fever. Scand. J. Immunol. 11: 623-628 (1980).

• Kawai K, Kitagawa H, Higashimori T, Matsui T, Fujiyama S, Monna T, Yamamoto S, Morisawa S. Experimental chronic non-suppurative destructive cholangitis in rabbits following immunization with bile duct antigen. Gastroenterol. Jpn. 15: 337-345 (1980).

• Keeling PW, Jones RB, Hilton PJ, Thompson RP. Reduced leucocyte zinc in liver disease. Gut 21: 561-564 (1980). *

• Kelts DG, Grand RJ. Inflammatory bowel disease in children and adolescents. Curr. Probl. Pediatr. 10: 1-40 (1980).

• Kemler BJ, Alpert E. Inflammatory bowel disease associated circulating immune complexes. Gut 21: 195-201 (1980). *

• Kiilerich S, Dietrichson O, Loud FB, Naestoft J, Christoffersen P, Juhl E, Kjems G, Christiansen C. Zinc depletion in alcoholic liver diseases. Scand. J. Gastroenterol. 15: 363-367 (1980).

• Kirk AP, Dooley JS, Hunt RH. Peptic ulceration in patients with chronic liver disease. Dig. Dis. Sci. 25: 756-760 (1980).

• Kirkpatrick RB, Killenberg PG. Effects of ethinylestradiol on enzymes catalyzing bile acid conjugation and sulfation. J. Lipid Res. 21: 895-901 (1980). *

• Kitis G, Holmes GK, Cooper BT, Thompson H, Allan RN. Association of coeliac disease and inflammatory bowel disease. Gut 21: 636-641 (1980). *

• Klasen EC, Biemond I, Weterman IT. alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands. Gut 21: 840-842 (1980). *

• Klotz U, Maier K, Fischer C, Heinkel K. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N. Engl. J. Med. 303: 1499-1502 (1980).

• Klouda PT, Harris R, Price DA. Linkage and association between HLA and 21-hydroxylase deficiency. J. Med. Genet. 17: 337-341 (1980). *

• Krulik M, Zylberait D, Vittecoq D, Audebert AA, Debray J. Primary biliary cirrhosis associated with acute disseminated lupus erythematosus. Nouv. Presse. Med. 9: 31-34 (1980).

• Kurki P, Miettinen A, Linder E, Pikkarainen P, Vuoristo M, Salaspuro MP. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 21: 878-884 (1980). *

• Lake-Bakaar G, McKavanagh S, Rubio CE, Epstein O, Summerfield JA. Measurement of trypsin in duodenal juice by radioimmunoassay. Gut 21: 402-407 (1980). *

• Lauterburg BH, Taswell HF, Pineda AA, Dickson ER, Burgstaler EA, Carlson GL. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 2: 53-55 (1980).

• Lehmann FG, Cramer P, Hillert U. Activity of small intestine alkaline phosphatase in the feces in chronic intestinal diseases. Z. Gastroenterol. 18: 208-215 (1980).

• Loginov AS, Aruin LI, Shepeleva SD. Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver. Arkh. Patol. 42: 50-55 (1980).

• Lupinetti M, Mehigan D, Cameron JL. Hepatobiliary complications of ulcerative colitis. Am. J. Surg. 139: 113-118 (1980).

• Mackay IR, Tait BD. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 79: 95-98 (1980).

• Matloff DS, Kaplan MM. D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis - successful treatment with plasmapheresis and immunosuppressives. Gastroenterology 78: 1046-1049 (1980).

• Matloff DS, Selinger MJ, Kaplan MM. Hepatic transaminase activity in alocholic liver disease. Gastroenterology 78: 1389-1392 (1980).

• Maton PN, Ellis HJ, Higgins MJ, Dowling RH. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids. Eur. J. Clin. Invest. 10: 325-332 (1980).

• Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, Lawson GH, Rowland AC, Berkhoff GA, Barthold SW. Agglutinins to bacteria in Crohn's disease. Gut 21: 376-380 (1980). *

• McPhie JL. Hepatic prolyl hydroxylase activity in human liver disease. Hepatogastroenterology 27: 277-282 (1980).

• Meek F, Khoury EL, Doniach D, Baum H. Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens. Clin. Exp. Immunol. 41: 43-54 (1980). *

• Miyachi K, Gupta RC, Dickson ER, Tan EM. Precipitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. Clin. Exp. Immunol. 39: 599-606 (1980). *

• Moller P, Vinje O, Fryjordet A. HLA antigens and sacro-iliitis in chronic prostatitis. Scand. J. Rheumatol. 9: 138-140 (1980).

• Mori N, Yoshikawa K, Ohno M. Psoriasis occuring in young monozygotic twins. J. Dermatol. 7: 71-73 (1980).

• Mosimann F, Burri B, Mosimann R. 9 cases of portal hypertension of rare etiology. Helv. Chir. Acta 46: 811-814 (1980).

• Nakayama F. Oral cholelitholysis - cheno versus urso: Japanese experience. Dig. Dis. Sci. 25: 129-134 (1980).

• Nielson HK. Multifocal idiopathic fibrosclerosis. Two cases with simultaneous occurrence of retroperitoneal fibrosis and Riedel's thyroiditis. Acta Med. Scand. 208: 119-123 (1980).

• Olsen H, Morland J. Hepatic damages caused by allopurinol. Tidsskr. Nor. Laegeforen. 100: 562-563 (1980).

• Orlin JB, Berkman EM, Matloff DS, Kaplan MM. Primary biliary cirrhosis and cold autoimmune hemolytic anemia: effect of partial plasma exchange. Gastroenterology 78: 576-578 (1980).

• Owen CA Jr. Copper and hepatic function. Ciba Found. Symp. 79: 267-282 (1980).

• Pace M, Fernandes D. Behaviour of the LAP (leucine-amino-peptidase) in the serum of blood in subjects affected of cirrhosis of the liver in stage ascitical. Quad. Sclavo. Diagn. 15: 1116-1119 (1980).

• Palmer KR, Duerden BI, Holdsworth CD. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 21: 851-854 (1980). *

• Phanichphant S, Boonpucknavig V. Allopurinol associated hypersensitivity. J. Med. Assoc. Thai. 63: 155-163 (1980).

• Phillpotts RJ, Hermon-Taylor J, Teich NM, Brooke BN. A search for persistent virus infection in Crohn's disease. Gut 21: 202-207 (1980). *

• Pirttiaho H, Pitkanen U, Rajasalmi M, Ahonen A. Comparison of three methods of measuring liver blood flow. Acta Radiol. Diagn. (Stockh.) 21: 535-539 (1980).

• Pletsityi KD, Blazheevich NV, Pereverzeva OG, Spirichev VB. Activity of certain mechanisms of natural immunity in white rats provided with different amounts of vitamin D. Vopr. Med. Khim. 26: 512-516 (1980).

• Pollard AC, Carey WF, Nelson PV, Poulos A, Hill GN. Enzymological diagnosis of a group of lysosomal storage diseases. Review of 5-year experience of 1600 patient-sample referrals. Med. J. Aust. 2: 549-553 (1980).

• Polter DE, Gruhl V, Eigenbrodt EH, Combes B. Beneficial effect of cholestyramine in sclerosing cholangitis. Gastroenterology 79: 326-333 (1980).

• Potter BJ, Elias E, Thomas HC, Sherlock S. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 78: 1034-1040 (1980).

• Quigley EM, Mills PR, Cole TP, Girdwood T, Scott-Harden WG, Watkinson G. 'The fat-encrusted colon'. A radiological abnormality of colonic mucosa occurring in patients with steatorrhoea. Scand. J. Gastroenterol. 15: 841-848 (1980).

• Rajaraman S, Deodhar SD, Carey WD, Salanga VD. Hashimoto's thyroiditis, primary biliary cirrhosis, and myasthenia gravis. Am. J. Clin. Pathol. 74: 831-834 (1980).

• Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology 78: 512-517 (1980).

• Reen DJ, O'Regan D. HLA antigen frequencies in an Irish population. Tissue Antigens 15: 369-372 (1980).

• Reginato AJ, Petrokubi R, Jasper CA. Juvenile hypertrophic osteoarthropathy associated with primary sclerosing cholangitis. Arthritis Rheum. 23: 1391-1395 (1980).

• Remacle JP, Pellissier JF, Chamlian A, Benkoel L, Aubert L, Monges H. Progressive ophthalmoplegia associated with asymptomatic primary biliary cirrhosis. Histologic, histochemical, cytochemical, and ultrastructural studies of muscle and liver biopsy specimens. Hum. Pathol. 11: S540-S548 (1980).

• Richter E, Epping J, Fuchshofen-Rockel M, Heusler H, Zilly W. Drug metabolism in patients with liver disease. Leber. Magen. Darm. 10: 234-240 (1980).

• Robinson BN, Roberts DF, Mather BA, Nelson R, Rowlatt AS. Coeliac disease and HLA: a family study. J. Immunogenet. 7: 381-391 (1980).

• Rodning CB, Erlandsen SL, Wilson ID. Immunohistochemical identification of immunoglobulin A on ultrathin tissue sections. Am. J. Anat. 157: 221-224 (1980).

• Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 2: 712-715 (1980).

• Rojanapo W, Olson JA, Lamb AJ. Biochemical and immunological characterization and the synthesis of rat intestinal glycoproteins following the induction of rapid synchronous vitamin A deficiency. Biochim. Biophys. Acta 633: 386-399 (1980).

• Routhier G, Epstein O, Janossy G, Thomas HC, Sherlock, Kung PC, Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet 2: 1223-1236 (1980).

• Roux M, Germain MA. Primary sclerosing cholangitis. J. Chir. (Paris) 117: 285-291 (1980).

• Sandilands GP, Galbraith I, Reid FM, Mills PR, MacSween RN. Immune-complex inhibition of lymphocyte Fc gamma-receptors in primary biliary cirrhosis: a possible immunomodulatory mechanism. Lancet 2: 9-13 (1980).

• Sarva RP, Fromm H, Farivar S, Sembrat RF, Mendelow H, Shinozuka H, Wolfson SK. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey. Gastroenterology 79: 629-636 (1980).

• Scharf Y, Zonis S. Histocompatibility antigens (HLA) and uveitis. Surv. Ophthalmol. 24: 220-228 (1980).

• Schattenkirchner M, Kruger K, Herzer P. B27-positive diseases. A new concept in rheumatology. MMW Munch. Med. Wochenschr. 122: 1725-1728 (1980).

• Schlierf G, Fischer H, Roche A, Stiehl A, Oster P, Schellenberg B, Vollmar J. The effect of bezafibrate on biliary lipids. MMW Munch. Med. Wochenschr. 122: 165-168 (1980).

• Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand. J. Gastroenterol. 15: 689-697 (1980).

• Schubotz R, Schneider J, Hausmann L, Muhlfellner G, Muhlfellner O, Kaffarnik H. Clinical experience with bezafibrate. Artery 8: 553-559 (1980).

• Schwartz SE, Siegelbaum SP, Fazio TL, Hubbell C, Henry JB. Regional enteritis: evidence for genetic transmission by HLA typing. Ann. Intern. Med. 93: 424-427 (1980).

• Shaffer EA. Gallstones: current concepts of pathogenesis and medical dissolution. Can. J. Surg. 23: 517-532, 557 (1980).

• Shoenfeld Y, Berliner S, Neeman A, Kadish U, Pinkhas J. Cryoglobulinemia in chronic liver diseases. Am. J. Gastroenterol. 74: 439-440 (1980).

• Sipponen P, Pikkarainen P, Vuori E, Salaspuro M. Copper deposits in fine needle aspiration biopsies in primary biliary cirrhosis. Acta Cytol. 24: 203-207 (1980).

• Sirisinha S, Darip MD, Moongkarndi P, Ongsakul M, Lamb AJ. Impaired local immune response in vitamin A-deficient rats. Clin. Exp. Immunol. 40: 127-135 (1980). *

• Solas MT, Zapata A. Gut-associated lymphoid tissue (GALT) in reptiles: intraepithelial cells. Dev. Comp. Immunol. 4: 87-97 (1980).

• Spolter L, Rice LI. Enzymatic sulfation of Triton X-100. Biochim. Biophys. Acta 612: 268-285 (1980).

• Stiehl A, Raedsch R, Czygan P, Gotz R, Manner C, Walker S, Kommerell B. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastroenterology 79: 1192-1198 (1980).

• Stoopen M, Dehesa M, Kimura K, Ramos-Martinez E. Secondary sclerosing cholangitis. Radiologic diagnosis and anatomoclinical correlation. Report of a case. Rev. Gastroenterol. Mex. 45: 193-203 (1980).

• Strauss RG, Ghishan F, Mitros F, Ebensberger JR, Kisker CT, Tannous R, Younoszai MK. Rectosigmoidal colitis in common variable immunodeficiency disease. Dig. Dis. Sci. 25: 798-801 (1980).

• Studdy PR, Bird R, Neville E, James DG. Biochemical findings in sarcoidosis. J. Clin. Pathol. 33: 528-533 (1980). *

• Summerfield JA, Scott J, Berman M, Ghent C, Bloomer JR, Berk PD, Sherlock S. Benign recurrent intrahepatic cholestasis: studies of bilirubin kinetics, bile acids, and cholangiography. Gut 21: 154-160 (1980). *

• Taal BG, Schalm SW, de Bruyn AM, de Rooy FW, Klein F. Serum IgM in primary biliary cirrhosis. Clin. Chim. Acta 108: 457-463 (1980).

• Toda G, Ikeda Y, Kako M, Oka H, Oda T. Mechanism of elevation of serum alkaline phosphatase activity in biliary obstruction: an experimental study. Clin. Chim. Acta 107: 85-96 (1980).

• Tornay AS Jr. Primary biliary cirrhosis: natural history. Am. J. Gastroenterol. 73: 223-226 (1980).

• Triger DR. Primary biliary cirrhosis: an epidemiological study. Br. Med. J. 281: 772-775 (1980). *

• Tsantoulas D, Perperas A, Portmann B, Eddleston AL, Williams R. Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis. Gut 21: 557-560 (1980). *

• Viteri AL, Greene JF Jr. Asymptomatic primary biliary cirrhosis. South. Med. J. 73: 163-165 (1980).

• Walker A, Cudworth AG. Type I (insulin-dependent) diabetic multiplex families: mode of genetic transmission. Diabetes 29: 1036-1039 (1980).

• Wells IP, Wheeler PG, Laws JW, Williams R. A new appearance of the common bile duct in sclerosing cholangitis. Br. J. Radiol. 53: 502-504 (1980).

• Werlin SL, Glicklich M, Jona J, Starshak RJ. Sclerosing cholangitis in childhood. J. Pediatr. 96: 433-435 (1980).

• Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79: 200-206 (1980).

• Willerson JT, Kulkarni P, Stone M, Lewis SE, Eigenbrodt E, Bonte FJ, Parkey RW, Buja LM. Localization of anti-mitochondrial antibody in experimental canine myocardial infarcts. Proc. Natl. Acad. Sci. U.S.A. 77: 6856-6859 (1980). *

• Williams R, MacDougall BR, Calne RY. The indications for and results of liver transplantation. Ann. Acad. Med. Singapore 9: 274-279 (1980).

• Willoughby CP, Piris J, Truelove SC. The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand. J. Gastroenterol. 15: 715-719 (1980).

• Wilson ID, McClain CJ, Erlandsen SL. Ileal Paneth cells and IgA system in rats with severe zinc deficiency: an immunohistochemical and morphological study. Histochem. J. 12: 457-471 (1980).

• Wood RA, Cuschieri A. Is sclerosing cholangitis complicating ulcerative colitis a reversible condition? Lancet 2: 716-718 (1980).

• Wright SH, Czaja AJ, Katz RS, Soloway RD. Systemic mycosis complicating high dose corticosteroid treatment of chronic active liver disease. Am. J. Gastroenterol. 74: 428-432 (1980).

• Zetterman RK, Woltjen JA. Suppressor cell activity in primary biliary cirrhosis. Dig. Dis. Sci. 25: 104-107 (1980).

Number of references = 176

www psc-literature.org